TRE in Type 2 Diabetes (See Food Study 3)

Description

Hyperglycemia in patients with Type 2 Diabetes Mellitus is initially treated with metformin coupled with intentional caloric restriction, which is difficult to sustain due to multiple barriers, including acquiring the necessary knowledge, teaching the intervention, cost of delivery and potential burden on quality of life. In contrast to intentionally restricting calories, time restricted eating (TRE), presents a simplified view of eating focused on restricting the eating window, which allows ad libitum intake per a person's dietary preferences during a daily fixed eating window. This study proposes a 24 week feasibility study to test if TRE is a viable alternative to Caloric Restriction in improving glycemic measures while accounting for weight loss in overweight/obese patients \[BMI:25-45 kg/m2\] with metformin-only treated Type 2 diabetes.

Conditions

Type2Diabetes

Study Overview

Study Details

Study overview

Hyperglycemia in patients with Type 2 Diabetes Mellitus is initially treated with metformin coupled with intentional caloric restriction, which is difficult to sustain due to multiple barriers, including acquiring the necessary knowledge, teaching the intervention, cost of delivery and potential burden on quality of life. In contrast to intentionally restricting calories, time restricted eating (TRE), presents a simplified view of eating focused on restricting the eating window, which allows ad libitum intake per a person's dietary preferences during a daily fixed eating window. This study proposes a 24 week feasibility study to test if TRE is a viable alternative to Caloric Restriction in improving glycemic measures while accounting for weight loss in overweight/obese patients \[BMI:25-45 kg/m2\] with metformin-only treated Type 2 diabetes.

TRE in Type 2 Diabetes Mellitus (See Food Study 3)

TRE in Type 2 Diabetes (See Food Study 3)

Condition
Type2Diabetes
Intervention / Treatment

-

Contacts and Locations

Minneapolis

University of Minnesota, Minneapolis, Minnesota, United States, 55455

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Overweight/obese adults with metformin-only treated type 2 diabetes
  • * 18-65 years old
  • * BMI:25-45 kg/m2
  • * HbA1c: 6.5-8.5%
  • * Self-reported weight must be stable \[±5 pounds\] for at least 3 months prior to the study
  • * Owns a smartphone.
  • * Active or anticipated pregnancy during the study
  • * type 2 diabetes treated with medications other than metformin
  • * presence of eating disorders as noted by screening survey.

Ages Eligible for Study

18 Years to 65 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

University of Minnesota,

Lisa Chow, MD, PRINCIPAL_INVESTIGATOR, University of Minnesota- Division of Endocrinology, Diabetes, and Metabolism

Study Record Dates

2026-04-30